Immix Biopharma (IMMX) Financial Statements

Compare

193 Followers

Immix Biopharma Financial Overview

Immix Biopharma's market cap is currently $431.66M. The company's EPS TTM is $-0.723; its P/E ratio is -5.86; Immix Biopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -364.50K	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -27.21M	$ -22.67M	$ -16.14M	$ -8.22M	$ -1.35M
EBITDA	$ -29.96M	$ -22.56M	$ -16.14M	$ -8.22M	$ -24.20M
Net Income	$ -29.44M	$ -21.61M	$ -15.43M	$ -8.23M	$ -24.38M
Balance Sheet
Cash & Short-Term Investments	$ 100.41M	$ 17.68M	$ 17.51M	$ 13.44M	$ 17.64M
Total Assets	$ 104.84M	$ 22.95M	$ 19.93M	$ 14.91M	$ 18.19M
Total Debt	$ 1.07M	$ 1.07M	$ 0.00	$ 0.00	$ 50.00K
Net Debt	$ -92.86M	$ -16.61M	$ -17.51M	$ -13.44M	$ -17.59M
Total Liabilities	$ 11.04M	$ 9.70M	$ 3.72M	$ 1.75M	$ 202.04K
Stockholders' Equity	$ 93.80M	$ 13.25M	$ 16.41M	$ 13.16M	$ 17.99M
Cash Flow
Free Cash Flow	$ -24.66M	$ -15.77M	$ -11.42M	$ -7.41M	$ -1.59M
Operating Cash Flow	$ -23.93M	$ -14.60M	$ -11.37M	$ -7.41M	$ -1.59M
Investing Cash Flow	$ -7.21M	$ -1.18M	$ -52.09K	$ 0.00	$ -802.00
Financing Cash Flow	$ 107.39M	$ 15.95M	$ 15.46M	$ 3.23M	$ 18.85M

Currency in USD

Immix Biopharma Earnings and Revenue History

Income Statement >

Immix Biopharma Debt to Assets

Balance Sheet >

Immix Biopharma Cash Flow

Cash Flow >

Immix Biopharma Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >